{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T18:05:23Z","timestamp":1704823523660},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,6,3]],"date-time":"2014-06-03T00:00:00Z","timestamp":1401753600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cel. Mol. Bioeng."],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s12195-014-0336-9","type":"journal-article","created":{"date-parts":[[2014,6,2]],"date-time":"2014-06-02T20:02:35Z","timestamp":1401739355000},"page":"320-333","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Quantitative Evaluation and Optimization of Co-drugging to Improve Anti-HIV Latency Therapy"],"prefix":"10.1007","volume":"7","author":[{"given":"Victor C.","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda E.","family":"Fong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas M.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddharth S.","family":"Dey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Miller-Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,3]]},"reference":[{"key":"336_CR1","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature11286","volume":"487","author":"NM Archin","year":"2012","unstructured":"Archin, N. M., A. L. Liberty, A. D. Kashuba, S. K. Choudhary, J. D. Kuruc, et al. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature 487:482\u2013485, 2012.","journal-title":"Nature"},{"key":"336_CR2","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1093\/nar\/gkm063","volume":"35","author":"M Barboric","year":"2007","unstructured":"Barboric, M., J. H. N. Yik, N. Czudnochowski, Z. Yang, R. Chen, et al. Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription. Nucleic Acids Res. 35:2003\u20132012, 2007.","journal-title":"Nucleic Acids Res."},{"key":"336_CR3","doi-asserted-by":"crossref","first-page":"e1000554","DOI":"10.1371\/journal.ppat.1000554","volume":"5","author":"J Blazkova","year":"2009","unstructured":"Blazkova, J., K. Trejbalova, F. Gondois-Rey, P. Halfon, P. Philibert, et al. CpG Methylation Controls Reactivation of HIV from Latency. PLoS Pathog. 5:e1000554, 2009.","journal-title":"PLoS Pathog."},{"key":"336_CR4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1128\/MMBR.20.4.243-258.1956","volume":"20","author":"CI Bliss","year":"1956","unstructured":"Bliss, C. I. The calculation of microbial assays. Bacteriol. Rev. 20:243\u2013258, 1956.","journal-title":"Bacteriol. Rev."},{"key":"336_CR5","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0092-8674(88)90099-2","volume":"53","author":"E B\u00f6hnlein","year":"1988","unstructured":"B\u00f6hnlein, E., J. W. Lowenthal, M. Siekevitz, D. W. Ballard, B. R. Franza, et al. The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV. Cell 53:827\u2013836, 1988.","journal-title":"Cell"},{"key":"336_CR6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood-2008-07-168393","volume":"113","author":"A Bosque","year":"2009","unstructured":"Bosque, A., and V. Planelles. Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells. Blood 113:58\u201365, 2009.","journal-title":"Blood"},{"key":"336_CR7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ymeth.2010.10.002","volume":"53","author":"A Bosque","year":"2011","unstructured":"Bosque, A., and V. Planelles. Studies of HIV-1 latency in an ex vivo model that uses primary central memory T cells. Methods 53:54\u201361, 2011.","journal-title":"Methods"},{"key":"336_CR8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nm.3489","volume":"20","author":"CK Bullen","year":"2014","unstructured":"Bullen, C. K., G. M. Laird, C. M. Durand, J. D. Siliciano, and R. F. Siliciano. New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo. Nat. Med. 20:425\u2013429, 2014.","journal-title":"Nat. Med."},{"key":"336_CR9","doi-asserted-by":"crossref","first-page":"5958","DOI":"10.1128\/JVI.00161-10","volume":"84","author":"JC Burnett","year":"2010","unstructured":"Burnett, J. C., K.-I. Lim, A. Calafi, J. J. Rossi, D. V. Schaffer, et al. Combinatorial latency reactivation for HIV-1 subtypes and variants. J. Virol. 84:5958\u20135974, 2010.","journal-title":"J. Virol."},{"key":"336_CR10","doi-asserted-by":"crossref","first-page":"e1000260","DOI":"10.1371\/journal.ppat.1000260","volume":"5","author":"JC Burnett","year":"2009","unstructured":"Burnett, J. C., K. Miller-Jensen, P. S. Shah, A. P. Arkin, and D. V. Schaffer. Control of stochastic gene expression by host factors at the HIV promoter. PLoS Pathog. 5:e1000260, 2009.","journal-title":"PLoS Pathog."},{"key":"336_CR11","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/529525","volume":"197","author":"SK Choudhary","year":"2008","unstructured":"Choudhary, S. K., N. M. Archin, and D. M. Margolis. Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cells. J. Infect. Dis. 197:1162\u20131170, 2008.","journal-title":"J. Infect. Dis."},{"key":"336_CR12","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1371\/journal.ppat.0030146","volume":"3","author":"X Contreras","year":"2007","unstructured":"Contreras, X., M. Barboric, T. Lenasi, and B. M. Peterlin. HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K\/Akt and activates HIV transcription. PLoS Pathog. 3:1459\u20131469, 2007.","journal-title":"PLoS Pathog."},{"key":"336_CR13","doi-asserted-by":"crossref","first-page":"6782","DOI":"10.1074\/jbc.M807898200","volume":"284","author":"X Contreras","year":"2009","unstructured":"Contreras, X., M. Schweneker, C. S. Chen, J. M. McCune, S. G. Deeks, et al. Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells. J. Biol. Chem. 284:6782\u20136789, 2009.","journal-title":"J. Biol. Chem."},{"key":"336_CR14","doi-asserted-by":"crossref","first-page":"6790","DOI":"10.1128\/JVI.74.15.6790-6799.2000","volume":"74","author":"JJ Coull","year":"2000","unstructured":"Coull, J. J., F. Romerio, J. M. Sun, J. L. Volker, K. M. Galvin, et al. The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1. J. Virol. 74:6790\u20136799, 2000.","journal-title":"J. Virol."},{"key":"336_CR15","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1073\/pnas.86.15.5974","volume":"86","author":"EJ Duh","year":"1989","unstructured":"Duh, E. J., W. J. Maury, T. M. Folks, A. S. Fauci, and A. B. Rabson. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc Natl Acad Sci USA 86:5974\u20135978, 1989.","journal-title":"Proc Natl Acad Sci USA"},{"key":"336_CR16","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.it.2012.07.001","volume":"33","author":"CM Durand","year":"2012","unstructured":"Durand, C. M., J. N. Blankson, and R. F. Siliciano. Developing strategies for HIV-1 eradication. Trends Immunol. 33:554\u2013562, 2012.","journal-title":"Trends Immunol."},{"key":"336_CR17","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1073\/pnas.93.13.6377","volume":"93","author":"S Emiliani","year":"1996","unstructured":"Emiliani, S., C. Van Lint, W. Fischle, P. Paras, Jr., M. Ott, et al. A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency. Proc. Natl. Acad. Sci. USA 93:6377\u20136381, 1996.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"336_CR18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/1743-422X-7-266","volume":"7","author":"G Fernandez","year":"2010","unstructured":"Fernandez, G., and S. L. Zeichner. Cell line-dependent variability in HIV activation employing DNMT inhibitors. Virol. J. 7:266, 2010.","journal-title":"Virol. J."},{"key":"336_CR19","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/8394","volume":"5","author":"D Finzi","year":"1999","unstructured":"Finzi, D., J. Blankson, J. D. Siliciano, J. B. Margolick, K. Chadwick, et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med. 5:512\u2013517, 1999.","journal-title":"Nat. Med."},{"key":"336_CR20","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","volume":"278","author":"D Finzi","year":"1997","unstructured":"Finzi, D., M. Hermankova, T. Pierson, L. M. Carruth, C. Buck, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278:1295\u20131300, 1997.","journal-title":"Science"},{"key":"336_CR21","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nchembio817","volume":"2","author":"JB Fitzgerald","year":"2006","unstructured":"Fitzgerald, J. B., B. Schoeberl, U. B. Nielsen, and P. K. Sorger. Systems biology and combination therapy in the quest for clinical efficacy. Nat. Chem. Biol. 2:458\u2013466, 2006.","journal-title":"Nat. Chem. Biol."},{"key":"336_CR22","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nature02171","volume":"426","author":"L Ganesh","year":"2003","unstructured":"Ganesh, L., E. Burstein, A. Guha-Niyogi, M. K. Louder, J. R. Mascola, et al. The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes. Nature 426:853\u2013857, 2003.","journal-title":"Nature"},{"key":"336_CR23","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1128\/JVI.78.12.6122-6133.2004","volume":"78","author":"Y Han","year":"2004","unstructured":"Han, Y., K. Lassen, D. Monie, A. R. Sedaghat, S. Shimoji, et al. Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes. J. Virol. 78:6122\u20136133, 2004.","journal-title":"J. Virol."},{"key":"336_CR24","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2013.09.020","volume":"155","author":"YC Ho","year":"2013","unstructured":"Ho, Y. C., L. Shan, N. N. Hosmane, J. Wang, S. B. Laskey, et al. Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell 155:540\u2013551, 2013.","journal-title":"Cell"},{"key":"336_CR25","doi-asserted-by":"crossref","first-page":"10914","DOI":"10.1128\/JVI.01208-07","volume":"81","author":"G Jiang","year":"2007","unstructured":"Jiang, G., A. Espeseth, D. J. Hazuda, and D. M. Margolis. c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter. J. Virol. 81:10914\u201310923, 2007.","journal-title":"J. Virol."},{"key":"336_CR26","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1093\/emboj\/cdg188","volume":"22","author":"A Jordan","year":"2003","unstructured":"Jordan, A., D. Bisgrove, and E. Verdin. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J. 22:1868\u20131877, 2003.","journal-title":"EMBO J."},{"key":"336_CR27","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/330489a0","volume":"330","author":"SY Kao","year":"1987","unstructured":"Kao, S. Y., A. F. Calman, P. A. Luciw, and B. M. Peterlin. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature 330:489\u2013493, 1987.","journal-title":"Nature"},{"key":"336_CR28","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1242510","volume":"342","author":"M Kasowski","year":"2013","unstructured":"Kasowski, M., S. Kyriazopoulou-Panagiotopoulou, F. Grubert, J. B. Zaugg, A. Kundaje, et al. Extensive variation in chromatin states across humans. Science 342:750\u2013752, 2013.","journal-title":"Science"},{"key":"336_CR29","doi-asserted-by":"crossref","first-page":"e1000495","DOI":"10.1371\/journal.ppat.1000495","volume":"5","author":"SE Kauder","year":"2009","unstructured":"Kauder, S. E., A. Bosque, A. Lindqvist, V. Planelles, and E. Verdin. Epigenetic regulation of HIV-1 latency by cytosine methylation. PLoS Pathog. 5:e1000495, 2009.","journal-title":"PLoS Pathog."},{"key":"336_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.emboj.7600759","volume":"25","author":"YK Kim","year":"2006","unstructured":"Kim, Y. K., C. F. Bourgeois, R. Pearson, M. Tyagi, M. J. West, et al. Recruitment of TFIIH to the HIV LTR is a rate-limiting step in the emergence of HIV from latency. EMBO J. 25:1\u20139, 2006.","journal-title":"EMBO J."},{"key":"336_CR31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1074-7613(00)80326-X","volume":"6","author":"S Kinoshita","year":"1997","unstructured":"Kinoshita, S., L. Su, M. Amano, L. A. Timmerman, H. Kaneshima, et al. The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells. Immunity 6:235\u2013244, 1997.","journal-title":"Immunity"},{"key":"336_CR32","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1039\/c2ib20009k","volume":"4","author":"K Miller-Jensen","year":"2012","unstructured":"Miller-Jensen, K., S. S. Dey, N. Pham, J. E. Foley, A. P. Arkin, et al. Chromatin accessibility at the HIV LTR promoter sets a threshold for NF-kappaB mediated viral gene expression. Integr. Biol. (Camb.) 4:661\u2013671, 2012.","journal-title":"Integr. Biol. (Camb.)"},{"key":"336_CR33","doi-asserted-by":"crossref","first-page":"e1003135","DOI":"10.1371\/journal.pcbi.1003135","volume":"9","author":"K Miller-Jensen","year":"2013","unstructured":"Miller-Jensen, K., R. Skupsky, P. S. Shah, A. P. Arkin, and D. V. Schaffer. Genetic selection for context-dependent stochastic phenotypes: Sp1 and TATA mutations increase phenotypic noise in HIV-1 gene expression. PLoS Comput. Biol. 9:e1003135, 2013.","journal-title":"PLoS Comput. Biol."},{"key":"336_CR34","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/326711a0","volume":"326","author":"G Nabel","year":"1987","unstructured":"Nabel, G., and D. Baltimore. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326:711\u2013713, 1987.","journal-title":"Nature"},{"key":"336_CR35","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.chom.2011.11.002","volume":"10","author":"M Ott","year":"2011","unstructured":"Ott, M., M. Geyer, and Q. Zhou. The control of HIV transcription: keeping RNA polymerase II on track. Cell Host Microbe 10:426\u2013435, 2011.","journal-title":"Cell Host Microbe"},{"key":"336_CR36","doi-asserted-by":"crossref","first-page":"11091","DOI":"10.1128\/JVI.76.21.11091-11103.2002","volume":"76","author":"V Quivy","year":"2002","unstructured":"Quivy, V., E. Adam, Y. Collette, D. Demonte, A. Chariot, et al. Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies. J. Virol. 76:11091\u201311103, 2002.","journal-title":"J. Virol."},{"key":"336_CR37","doi-asserted-by":"crossref","first-page":"e6093","DOI":"10.1371\/journal.pone.0006093","volume":"4","author":"S Reuse","year":"2009","unstructured":"Reuse, S., M. Calao, K. Kabeya, A. Guiguen, J.-S. Gatot, et al. Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection. PLoS ONE 4:e6093, 2009.","journal-title":"PLoS ONE"},{"key":"336_CR38","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.1165706","volume":"323","author":"DD Richman","year":"2009","unstructured":"Richman, D. D., D. M. Margolis, M. Delaney, W. C. Greene, D. Hazuda, et al. The challenge of finding a cure for HIV infection. Science 323:1304\u20131307, 2009.","journal-title":"Science"},{"key":"336_CR39","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1200\/JCO.1986.4.12.1835","volume":"4","author":"EK Rowinsky","year":"1986","unstructured":"Rowinsky, E. K., D. S. Ettinger, L. B. Grochow, R. B. Brundrett, A. E. Cates, et al. Phase I and pharmacologic study of hexamethylene bisacetamide in patients with advanced cancer. J. Clin. Oncol. 4:1835\u20131844, 1986.","journal-title":"J. Clin. Oncol."},{"key":"336_CR40","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0092-8674(90)90121-T","volume":"62","author":"MJ Selby","year":"1990","unstructured":"Selby, M. J., and B. M. Peterlin. Trans-activation by HIV-1 Tat via a heterologous RNA binding protein. Cell 62:769\u2013776, 1990.","journal-title":"Cell"},{"key":"336_CR41","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1038\/sj.emboj.7601928","volume":"26","author":"M Tyagi","year":"2007","unstructured":"Tyagi, M., and J. Karn. CBF-1 promotes transcriptional silencing during the establishment of HIV-1 latency. EMBO J. 26:4985\u20134995, 2007.","journal-title":"EMBO J."},{"key":"336_CR42","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1128\/JVI.01519-09","volume":"84","author":"M Tyagi","year":"2010","unstructured":"Tyagi, M., R. J. Pearson, and J. Karn. Establishment of HIV latency in primary CD4+ cells is due to epigenetic transcriptional silencing and P-TEFb restriction. J. Virol. 84:6425\u20136437, 2010.","journal-title":"J. Virol."},{"key":"336_CR43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2005.06.006","volume":"122","author":"LS Weinberger","year":"2005","unstructured":"Weinberger, L. S., J. C. Burnett, J. E. Toettcher, A. P. Arkin, and D. V. Schaffer. Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity. Cell 122:169\u2013182, 2005.","journal-title":"Cell"},{"key":"336_CR44","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.emboj.7600900","volume":"25","author":"SA Williams","year":"2006","unstructured":"Williams, S. A., L.-F. Chen, H. Kwon, C. M. Ruiz-Jarabo, E. Verdin, et al. NF-\u03baB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J. 25:139\u2013149, 2006.","journal-title":"EMBO J."}],"container-title":["Cellular and Molecular Bioengineering"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12195-014-0336-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12195-014-0336-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12195-014-0336-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T13:01:50Z","timestamp":1597928510000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12195-014-0336-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["336"],"URL":"https:\/\/doi.org\/10.1007\/s12195-014-0336-9","relation":{},"ISSN":["1865-5025","1865-5033"],"issn-type":[{"value":"1865-5025","type":"print"},{"value":"1865-5033","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,3]]}}}